Sun Pharma gets 3 observations from USFDA for Halol plant

The United States Food and Drug Administration (USFDA) conducted the Good Manufacturing Practices (GMP) inspection of the company's Halol facility from February 12-23, 2018.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news